Expand VALN Menu
VALN MENU

VALN Latest Press Releases

-- August 14, 2026 --

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency Globe Newswire 1:00 AM
Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency Business Wire 1:00 AM

-- August 13, 2026 --

Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates Globe Newswire 1:00 AM

-- July 22, 2026 --

Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026 Globe Newswire 11:45 AM

-- June 25, 2026 --

Valneva Announces Successful Outcome of its Annual General Meeting Globe Newswire 11:45 AM

-- June 4, 2026 --

Valneva Announces Availability of Documentation for its Annual General Meeting Globe Newswire 1:00 AM

-- May 28, 2026 --

Valneva to Participate at U.S. and European Investor Conferences in June Globe Newswire 11:45 AM

-- May 13, 2026 --

Valneva Reports First Quarter 2026 Financial Results and Provides Corporate Updates Globe Newswire 1:00 AM

-- May 5, 2026 --

Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026 Globe Newswire 11:45 AM

-- April 30, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN PRNewswire 10:40 PM
Valneva Announces the Successful Completion of an EUR 84 million Reserved Offering Globe Newswire 1:15 AM

-- April 28, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN Globe Newswire 6:26 PM

-- April 21, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Valneva SE - VALN Globe Newswire 5:21 PM
Market Data Delayed 15 Minutes